About: http://webisa.webdatacommons.org/270821227

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	CoPlex Therapeutics, co-founded by UK Department of Chemistry researchers Burt Lynn and Mark Lovell and CEO John Beran, is developing treatments for mild cognitive impairment, Alzheimer's and other neurological disorders.
http://www.w3.org/ns/prov#wasQuotedFrom	uky.edu